China's Mehow Builds Medical Molding Plant in Malaysia

Chinese medical injection molder Mehow Innovation Ltd. is investing more than $20 million in a new facility in Malaysia, its first outside China, as it responds to global customers who want it to diversify outside its home country.
The Shenzhen-based company, which has more than 85 injection presses and 1,000 employees at its headquarters factory, opened the first phase of its new plant in Penang, Malaysia, earlier this year.
It has started a second phase there that will be completed by the of the year, which will give it a little more than 20 molding machines in Malaysia.
Feng Yuan, director of business development, said the move is motivated by customers who in general want to reduce the risk to their own supply chains from both natural disasters and political and economic situations.
"One of the reasons is risk mitigation," said Yuan in an interview at the Chinaplas trade fair in Guangzhou. "We needed to have two sites to make the parts for our main customers. … Our customers encourage us to have another site overseas."
The company manufactures parts for global suppliers like Cochlear Ltd. and Chinese medical device makes like Shenzhen-based Mindray Medical International Ltd.
Mehow was exhibiting at Chinaplas, which typically draws in machinery and material companies as exhibitors rather than parts makers, because it wanted to promote a newer business it's developing in molding parts from liquid silicone rubber.
But Yuan said the Malaysia expansion is focused on the company's traditional thermoplastics molding and manufacturing operations, for now at least.
The Penang facility opened earlier this year with seven injection molding machines, and in its next phase that will open later this year, it will install another 15 molding machines, all from the German supplier Arburg, Yuan said.
It has about 80 employees in Malaysia now, and Yuan said the investment there could rise to $25 million.
More than 90 percent of its manufacturing is exported and about 75 percent of its sales are in thermoplastic parts, with the other quarter in LSR. About 65 of its molding machines in Shenzhen are focused on thermoplastic molding.
Yuan said the company has focused on upgrading: three-and-a-half years ago it set up a research and development center in Shenzhen, where it now employs about 100 engineers.
He said the privately held company does not disclose sales figures but he said they've risen more than 30 percent annually for the last five years.
2026-10-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
South Korea to Impose Anti-Dumping Duties on Caustic Soda: Chinese Mainland Firms Face Up to 22.21%, Taiwan Region 38.89%
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
Three Major Indian Chemical Investments Target China's PC Exports
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
South Korea Initiates Anti-Dumping Probe on Chinese PVC Suspension Resin, Involving Tianjin Bohua and Wanhua Chemical
-
China Keeps Registering Pesticides
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
Recommend Reading
-
French Cosmetics Exports Poised for First Drop in Over Two Decades in 2025
-
When the Skin of Ships Gets More Expensive: A 30% Price Shock Is Quietly Rewriting the Cost Floor of Global Shipping
-
Death Toll from Fire at China-Russia Amur Polyolefins Project Rises to 15 as Construction Continues
-
Japanese Plastics Market Accelerates its Shifts to Recycled Materials and Bioplastics
-
Aekyung Chemical Plans to Sell Its Ningbo Subsidiary
-
Business Society’s Market Outlook for Methanol on August 28, 2026: Weak and Volatile
-
Insufficient Downstream Demand Leaves Cyclohexane Price Gains Weak in September
-
Business Society’s September 2, 2026 Methanol Market Outlook: Volatile Pattern
-
Supply and Demand Continue to Reduce Inventories, PTA Prices Fluctuate Higher
-
Business Society’s Market Outlook for Soda Ash on August 27, 2026: Clearly Downward